Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Liabilities from Discontinued Operations (2017 - 2023)

Lifecore Biomedical, Inc. \De\ has reported Liabilities from Discontinued Operations over the past 6 years, most recently at 518000.0 for Q1 2023.

  • For Q1 2023, Liabilities from Discontinued Operations fell 79.23% year-over-year to 518000.0; the TTM value through Feb 2023 reached 518000.0, down 79.23%, while the annual FY2022 figure was 4744000.0, 31.89% down from the prior year.
  • Liabilities from Discontinued Operations for Q1 2023 was 518000.0 at Lifecore Biomedical, Inc. \De\, down from 16832000.0 in the prior quarter.
  • Over five years, Liabilities from Discontinued Operations peaked at 66454000.0 in Q4 2020 and troughed at 518000.0 in Q1 2023.
  • A 4-year average of 16120727.27 and a median of 6146000.0 in 2021 define the central range for Liabilities from Discontinued Operations.
  • Biggest five-year swings in Liabilities from Discontinued Operations: plummeted 92.75% in 2021 and later surged 249.14% in 2022.
  • Year by year, Liabilities from Discontinued Operations stood at 66454000.0 in 2020, then plummeted by 92.75% to 4821000.0 in 2021, then surged by 249.14% to 16832000.0 in 2022, then tumbled by 96.92% to 518000.0 in 2023.
  • Business Quant data shows Liabilities from Discontinued Operations for LFCR at 518000.0 in Q1 2023, 16832000.0 in Q4 2022, and 2153000.0 in Q3 2022.